Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus
Clinical trial NCT05048238 · COMPLETED
Trial details
- NCT number
- NCT05048238
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2024-02-15
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.